Lung cancer (Amsterdam, Netherlands) · 2026
Immune signatures in NSCLC associated pleural effusions and implications for prognosis.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lombardi Matilde, Gerckens Michael, Alkan Gülümser Hale, Khmelovska Daria, Gaedtke Lena, Weiß Nicole, Mertens Georg, Krämer Johannes, Melzer Thomas, Leuschner Gabriela, Yildirim A Önder, Kneidinger Nikolaus, Behr Jürgen, Stoleriu Gabriel Mircea, Mümmler Carlo, Kauffmann-Guerrero Diego
Аннотация
BACKGROUND: Pleural effusions (PEs) are frequent in patients with non-small cell lung cancer (NSCLC) and have prognostic implications. Detection of malignant cells in pleural fluid defines metastatic disease. However, PE cytology has limited sensitivity, leaving a substantial number of PEs cytology negative (Cyt-). We assessed the prognostic significance of cytology positive (Cyt+) and negative effusions and compared biochemical, cellular, and cytokine profiles of NSCLC associated PEs.
METHODS: In this retrospective analysis of a prospectively collected prospective multicenter cohort study, PEs were collected from patients with confirmed NSCLC between 2021 and 2025. Effusions were classified as Cyt + or Cyt - based on cytopathology. Clinical data, pleural fluid biochemistry, and differential cell counts were recorded. Cytokine concentrations were measured in PE supernatant using a multiplex ELISA panel and correlated with survival.
RESULTS: 111 NSCLC patients with PEs were included in this study (51 Cyt + and 60 Cyt - cases). Cyt + effusions were characterized by significantly lower pH and higher lactate, LDH, and protein concentrations. One year survival was not different in both groups. High pleural lymphocyte counts and a lower pleural neutrophil to lymphocyte ratio were associated with mortality. Cytokine profiling revealed significantly lower IL-5 levels in Cyt + effusions, while other cytokines were comparable. Higher Th2 associated cytokine levels (IL-4 and IL-5) correlated with improved survival independent of cytology status.
CONCLUSION: NSCLC-associated cytology positive PEs show distinct immunological features. Survival in patients with Cyt + PEs was similar to those with Cyt- effusions. Pleural immune composition, particularly lymphocyte related markers and Th2 cytokines, may provide additional prognostic information beyond cytology alone.
METHODS: In this retrospective analysis of a prospectively collected prospective multicenter cohort study, PEs were collected from patients with confirmed NSCLC between 2021 and 2025. Effusions were classified as Cyt + or Cyt - based on cytopathology. Clinical data, pleural fluid biochemistry, and differential cell counts were recorded. Cytokine concentrations were measured in PE supernatant using a multiplex ELISA panel and correlated with survival.
RESULTS: 111 NSCLC patients with PEs were included in this study (51 Cyt + and 60 Cyt - cases). Cyt + effusions were characterized by significantly lower pH and higher lactate, LDH, and protein concentrations. One year survival was not different in both groups. High pleural lymphocyte counts and a lower pleural neutrophil to lymphocyte ratio were associated with mortality. Cytokine profiling revealed significantly lower IL-5 levels in Cyt + effusions, while other cytokines were comparable. Higher Th2 associated cytokine levels (IL-4 and IL-5) correlated with improved survival independent of cytology status.
CONCLUSION: NSCLC-associated cytology positive PEs show distinct immunological features. Survival in patients with Cyt + PEs was similar to those with Cyt- effusions. Pleural immune composition, particularly lymphocyte related markers and Th2 cytokines, may provide additional prognostic information beyond cytology alone.